Although this initial case only involves the drug manufacturers as defendants, it is anticipated that more claims and lawsuits targeting not only Ozempic, but also other GLP-1 drugs, will emerge
Because GLP-1 drugs are expensive, can be difficult to access, and have significant side effects, many people have sought to increase their production of the natural hormone via nutritional modifications
Research has shown that polymorphisms in the GLP-1 receptor gene may influence the effectiveness of treatment, affecting both appetite regulation and insulin sensitivity
Why Choose Us
Manufacturers may expect significant levels of competition, specifically within the GLP-1 RA class, and will need to differentiate their assets and value proposition to remain competitive and maintain and/or grow their market share
"The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions." Lancet Diabetes Endocrinol